Volume 11, Issue 6, Pages (June 2012)

Slides:



Advertisements
Similar presentations
Volume 132, Issue 4, Pages (April 2007)
Advertisements

Volume 2, Issue 4, Pages (October 2007)
Volume 13, Issue 6, Pages (June 2013)
Volume 11, Issue 11, Pages (June 2015)
Volume 7, Issue 5, Pages (May 2010)
Volume 15, Issue 1, Pages (January 2014)
Volume 22, Issue 5, Pages (May 2012)
Volume 71, Issue 5, Pages e5 (September 2018)
The UPEC Pore-Forming Toxin α-Hemolysin Triggers Proteolysis of Host Proteins to Disrupt Cell Adhesion, Inflammatory, and Survival Pathways  Bijaya K.
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Volume 20, Issue 3, Pages (September 2016)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 132, Issue 4, Pages (April 2007)
Volume 5, Issue 1, Pages (January 2009)
Volume 9, Issue 6, Pages (June 2011)
Volume 36, Issue 6, Pages (June 2012)
Volume 18, Issue 2, Pages (August 2015)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 36, Issue 4, Pages (April 2012)
Volume 5, Issue 3, Pages (March 2009)
Volume 17, Issue 6, Pages (June 2015)
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 9, Issue 3, Pages (November 2014)
Volume 9, Issue 6, Pages (June 2011)
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Volume 13, Issue 6, Pages (June 2013)
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Volume 17, Issue 4, Pages (April 2015)
Volume 6, Issue 3, Pages (September 2009)
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
c-Src Activates Endonuclease-Mediated mRNA Decay
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 16, Issue 3, Pages (September 2014)
Volume 11, Issue 11, Pages (June 2015)
Volume 16, Issue 12, Pages (June 2006)
Volume 17, Issue 6, Pages (June 2015)
Volume 16, Issue 6, Pages (December 2014)
Volume 19, Issue 6, Pages (September 2005)
Volume 15, Issue 2, Pages (February 2014)
Volume 27, Issue 3, Pages (September 2007)
Volume 16, Issue 3, Pages (September 2014)
Volume 13, Issue 4, Pages (April 2008)
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions  Carolyn B. Coyne, Jeffrey M. Bergelson  Cell 
Volume 20, Issue 5, Pages (November 2016)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 8, Issue 4, Pages (October 2005)
Volume 1, Issue 4, Pages (June 2007)
Volume 34, Issue 5, Pages (May 2011)
Coxsackievirus Entry across Epithelial Tight Junctions Requires Occludin and the Small GTPases Rab34 and Rab5  Carolyn B. Coyne, Le Shen, Jerrold R. Turner,
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Volume 9, Issue 2, Pages (February 2011)
TRAF4 is required for EGFR activation in response to EGF stimulation.
Volume 2, Issue 6, Pages (December 2007)
Volume 38, Issue 1, Pages (April 2010)
Volume 16, Issue 5, Pages (May 2009)
Volume 13, Issue 1, Pages (October 2015)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Suman Paul, Anuj K. Kashyap, Wei Jia, You-Wen He, Brian C. Schaefer 
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Volume 14, Issue 1, Pages (July 2013)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Volume 21, Issue 1, Pages (January 2017)
Translocation of a Vibrio cholerae Type VI Secretion Effector Requires Bacterial Endocytosis by Host Cells  Amy T. Ma, Steven McAuley, Stefan Pukatzki,
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Volume 11, Issue 6, Pages 576-586 (June 2012) The Helicobacter pylori Virulence Effector CagA Abrogates Human β-Defensin 3 Expression via Inactivation of EGFR Signaling  Bianca Bauer, Ervinna Pang, Carsten Holland, Mirjana Kessler, Sina Bartfeld, Thomas F. Meyer  Cell Host & Microbe  Volume 11, Issue 6, Pages 576-586 (June 2012) DOI: 10.1016/j.chom.2012.04.013 Copyright © 2012 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 H. pylori-Induced hBD3 Exerts Strong Antimicrobial Activity (A) AGS cells were infected with H. pylori wild-type strains P1, P12, and G27 (all MOI 100) for the indicated time points. Infected and noninfected (NI) cells were lysed and analyzed for hBD3 expression by immunoblot. Actin serves as a loading control. (B) P1 was heat inactivated via incubation at indicated temperatures for 45 min. AGS cells were infected with untreated (P1), bacterial supernatant (SN), and heat inactivated bacteria for 8 hr (MOI 100). Bacterial incubation medium (BHI) was used as control. Cells were lysed and analyzed for hBD3 expression by immunoblot. Actin serves as a loading control. (C) Antimicrobial activity assay of hBD3- and hBD2-treated P1. Bacteria (1 × 105) were incubated for 2 hr with the indicated peptide concentrations in the indicated NaCl concentrations (PBS). Colony forming units/ml (CFU/ml) were quantified 3 days later. Data are expressed as percentage bacterial survival relative to the untreated control (UT). (D) Confocal immunofluorescence staining of P1 infected tissue culture (Fallopian tubes). hBD3 expression was detected with an anti hBD3 antibody (green). H. pylori was visualized with an anti-urease B antibody (red). Nuclei were stained with DraQ5 (blue). The scale bar represents 50 μm. (E) Stable hBD3 knockdown cells (AGS_hBD3_KD_1 and AGS_hBD3_KD_2) were infected with P1 (MOI 100). 24 hr p.i., a CFU assay was performed to quantify the bacterial survival rate. AGS cells expressing shRNA against luciferase (AGS_Luci) were used as control. (F) RT-PCR analysis of hBD3 mRNA expression in P1 infected (MOI 100; 4 hr p.i.) stable shRNA-mediated hBD3 knockdown cells (AGS_hBD3 KD_1 and AGS_hBD3 KD_2). AGS_Luci cells serve as control. Blots in (A) and (B) and images in (C), (E), and (F) are representative of three independent experiments. Data in (C), (E), and (F) show mean ± SD of three technical replicates. Statistical significance in (E) was calculated with t test analysis (∗∗ indicates p value < 0.009). See also Figure S1. Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 H. pylori Inhibits Expression of hBD3 in Gastric Epithelial Cells during Prolonged Infection (A) RT-PCR analysis of hBD3 mRNA expression in infected cells (P1, MOI 100). Expression is relative to noninfected control (NI). Data show mean ± SD of three independent experiments. h p.i., hours postinfection. (B) Immunoblot of hBD3 expression at 2, 24, 48, and 72 hr p.i. (P1; MOI 20, 100). Actin serves as a loading control. The blot is representative of three independent experiments. (C) Confocal images of hBD3 expression in P1-infected AGS cells (24 and 48 hr; MOI 20) and noninfected cells (NI). hBD3 was stained with an anti-hBD3 antibody (red), and bacteria are visualized with an anti-CagA antibody (green). Nuclei are stained with DraQ5 (blue). Scale bars represent 10 μm. Images are representative of three independent experiments. (D) 3D reconstruction of one representative confocal image of 24 hr infected cells (red, hBD3; green, bacteria; blue, DNA). (E) Quantification of mean hBD3 signal intensity of at least three independent experiments of noninfected (NI), 24 hr infected, and 48 hr infected cells, shown as mean ± SD. Statistical significance was calculated using t test analysis (∗ indicates p value < 0.05). See also Figure S2. Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 3 EGFR Regulation of hBD3 Expression Is Dependent on Duration of Infection AGS cells were infected with P1 (MOI 100). (A–C) Before and during infection cells were treated with inhibitors against EGFR (A and B) or MAP (UO126; 20 μM) or Janus (AG490; 20 μM) kinases (C). (A) Immunoblot analysis of hBD3 expression of infected and noninfected (NI) cells 24 hr p.i. treated with indicated concentration of AG1478. Actin serves as a loading control. (B) RT-PCR analysis of hBD3 mRNA expression in P1-infected and noninfected (NI) cells after 8 hr of infection (AG1478, Gefitinib; 10 μM). DMSO serves as a control. (C) Immunoblot analysis of hBD3 expression of infected and noninfected (NI) cells 2 and 4 hr p.i. treated with UO126 or AG490. Actin serves as a loading control. (D) EGFR phosphorylation was analyzed after different time points of infection by immunoblotting with an anti-phosphotyrosine antibody after treatment of infected cells with 100 ng/ml EGF for 5 min. Phosphorylation intensities were quantified (pYEGFR) and expressed as a percentage relative to noninfected (NI) stimulated cells. (E) Immunoblot analysis of EGFR phosphorylation at specific tyrosines in infected (P1) and noninfected (NI) cells (24 hr p.i.). Antibodies against pY845, pY1045, pY992, and pY1068 were used. EGFR serves as a loading control. Blots in (A), (C), and (E) are representative of three independent experiments. Data in (B) and (D) are mean ± SD of three independent experiments. See also Figure S3. Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 4 CagA-Dependent Selective Inhibition of EGFR Inhibits hBD3 Synthesis AGS cells were infected with either P1 or the isogenic deletion mutants P1ΔcagA and P1ΔvirB11 (MOI 100; 24 hr) and subsequently treated with 100 ng/ml EGF for 5 min. (A) RT-PCR analysis of hBD3 mRNA expression infected with P1ΔcagA. Data are expressed as a percentage relative to noninfected (NI) cells. (B) Immunoblot analysis of EGFR and CagA phosphorylation with an anti-phosphotyrosine antibody. Actin serves as a loading control. (C) AGS cells were transfected with EGFR constructs encoding either constitutively active EGFR (EGFR L858R) or wild-type EGFR (EGFR WT). Twenty-four hours after transfection, cells were infected with P1. Cellular RNA was extracted and hBD3 mRNA measured by RT-PCR 24 hr p.i. (D) Immunoblot analysis of EGFR and CagA phosphorylation with an anti-phosphotyrosine antibody. Actin serves as a loading control. AGS cells were infected with the wild-type strains P1 or G27 and with P1ΔcagA, the recomplemented mutant P1ΔcagA/cagA, or the nonphosphorylatable CagA mutant G27cagAEPISA. Data in (A) and (C) are mean ± SD of three technical replicates. Bar graphs in (A) and (C) and blots in (B) and (D) are representative of three independent experiments. See also Figure S4. Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 5 Inhibition of EGFR and hBD3 Expression via SHP-2 Enables Bacterial Survival (A) AGS cells were transfected with siRNAs targeting SHP-2 (siRNA SHP-2) or luciferase control (siRNA Luci). Three days after transfection, cells were infected with P1 (MOI 100) and analyzed 24 hr later. For EGFR phosphorylation analysis, infected and noninfected (NI) cells were stimulated with EGF (100 ng/ml) for 5 min. EGFR phosphorylation (EGFR pY) was analyzed by immunoblotting with an anti-phosphotyrosine antibody. Actin serves as a loading control. Graph depicts phosphorylation intensities (pEGFR) as a percentage relative to noninfected unstimulated cells. (B) A stable SHP-2 knockdown cell line was generated via genomic lentiviral shRNA integration (SHP2-4KD). The graph shows hBD3 mRNA expression in infected and noninfected (NI) AGS and SHP2-4KD cells as measured by RT-PCR. (C) Confocal immunofluorescence analysis of infected AGS and SHP2-4KD cells (MOI 20). Cells were stained with an anti-hBD3 antibody (red) or anti-CagA antibody (blue) to visualize H. pylori. Knockdown cells express GFP (green) as a reporter construct for efficient lentiviral integration. Two representative figures for each sample are shown. The scale bar represents 10 μm. (D) Quantification of hBD3 signal intensity in AGS WT and SHP-2-deficient cells 48 hr p.i. in relation to AGS WT cells (100%). (E) Quantification of bacterial signal intensity of SHP2-4KD cells 24 hr p.i. (MOI 20) in relation to AGS WT cells. (F and G) Bacterial viability was monitored by counting CFUs of infected cells 24 hr p.i. (F) Numbers of free swimming (supernatant; SN) and attached (pellet; PE) bacteria, expressed as colony-forming units/ml (CFU/ml), in AGS and SHP2-4KD cells. (G) Cells were transfected with siRNA against hBD3 or control siRNA (Allstars). Three days after transfection, cells were infected with P1 (MOI 100). CFU was assessed from attached bacteria. Data in (A), (B), and (D)–(G) show mean ± SD of three technical replicates. The blot in (A), bar graphs in (B) and (D)–(G), and images in (C) and (E) are representative of three independent experiments. Statistical significance in (D)–(G) was calculated with t test analysis (∗∗∗ indicates p value < 0.0007; ∗ indicates p value < 0.05). See also Figure S5. Cell Host & Microbe 2012 11, 576-586DOI: (10.1016/j.chom.2012.04.013) Copyright © 2012 Elsevier Inc. Terms and Conditions